Clinical Trials Directory

Trials / Completed

CompletedNCT01232465

Impact of Sperm DNA Integrity on In Vitro Cycles

Status
Completed
Phase
Study type
Observational
Enrollment
420 (actual)
Sponsor
Northwell Health · Academic / Other
Sex
Male
Age
Healthy volunteers
Not accepted

Summary

Sperm DNA integrity will be measured via the Toluidine Blue Assay (TBA) for patients undergoing In Vitro Fertilization (IVF); the study will determine correlations, if any, between IVF success and sperm DNA integrity.

Conditions

Timeline

Start date
2010-10-01
Primary completion
2013-02-01
Completion
2013-09-01
First posted
2010-11-02
Last updated
2014-04-11
Results posted
2014-03-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01232465. Inclusion in this directory is not an endorsement.

Impact of Sperm DNA Integrity on In Vitro Cycles (NCT01232465) · Clinical Trials Directory